Life Technologies Names Alan Sachs as Head of Global Research and Development
News Feb 01, 2012
The former Vice President, Exploratory and Translational Sciences for Merck Research Laboratories, has joined the company as Head of Global Research and Development.
Sachs will play a key role in driving technology strategy and further shaping Life Technologies' culture of high-performance R&D and product innovation. He will also lead the company's Global Science and Innovation Office and serve as the principal liaison to the external scientific community.
"Alan brings strong leadership qualities in research and development that's grounded in a deep understanding of biology – attributes that will be paramount to drive our efforts in developing innovative products for our customers," said Mark Stevenson, President and Chief Operating Officer at Life Technologies.
A former Associate Professor in the Division of Biochemistry and Molecular Biology at University of California, Berkeley, and Whitehead fellow at the Whitehead Institute for Biomedical Research, Sachs has published more than 70 papers in scientific journals. After a nine-year career in academia, he spent 10 years in leadership roles at Merck Research Laboratories, where he oversaw projects that included all aspects of molecular profiling, the development of RNA therapeutics, biomarker discovery for the pre-clinical and clinical markets, and human disease modeling.
Sachs received his Ph.D. in Cell Biology from Stanford University in 1987, his M.D. from the Stanford School of Medicine in 1989, and his B.A. in Biochemistry from Cornell University in 1982.
"Life Technologies has a strong legacy of being on the leading edge of technology that's designed to help researchers around the world move science forward," Sachs said. "I'm looking forward to being a part of that legacy and contributing new strategies to advance it even further."
LogicTRN Model Illuminates Regulatory Gene FrameworkNews
A newly devised algorithm called LogicTRN has the potential to unravel the complexities of genetic regulation.READ MORE
BIA Separations appoints Pete Gagnon as Chief Scientific OfficerNews
Appointment will drive new product and applications development.READ MORE